[1]周玲生.子宫腺肌病178例临床病理分析[J].新乡医学院学报,2001,18(05):363-364.
点击复制

子宫腺肌病178例临床病理分析/HTML
分享到:

《新乡医学院学报》[ISSN:1004-7239/CN:41-1186/R]

卷:
18
期数:
2001年05期
页码:
363-364
栏目:
专家论坛
出版日期:
2001-09-20

文章信息/Info

作者:
周玲生
(南阳卫生学校, 河南南阳473058)
关键词:
子宫腺肌病子宫内膜异位症子宫肌瘤

相似文献/References:

[1]李 红,石瑞珊,刘莉娜.子宫内膜异位症28 例误诊原因分析[J].新乡医学院学报,2003,20(01):058.
[2]李 红,石瑞珊,刘莉娜.子宫内膜异位症28例误诊原因分析[J].新乡医学院学报,2003,20(01):058.
[3]黄 蓉,邓宇傲,王 玲,等.CYP17基因多态性与子宫内膜异位症的相关性[J].新乡医学院学报,2017,34(2):129.[doi:10.7683/xxyxyxb.2017.02.013]
 HUANG Rong,DENG Yu-ao,WANG Ling,et al.Relationship between CYP17 gene polymorphism and endometriosis[J].Journal of Xinxiang Medical University,2017,34(05):129.[doi:10.7683/xxyxyxb.2017.02.013]
[4]南 燕,侯妍妍,李玉洁.不同剂量米非司酮对子宫内膜异位症大鼠异位内膜组织中环氧合酶-2和血管内皮生长因子表达的影响[J].新乡医学院学报,2019,36(6):521.[doi:10.7683/xxyxyxb.2019.06.005]
 NAN Yan,HOU Yan-yan,LI Yu-jie.Effect of different doses of mifepristone on the expression of cyclooxygenase-2 and vascular endothelial growth factor in endometriosis rats[J].Journal of Xinxiang Medical University,2019,36(05):521.[doi:10.7683/xxyxyxb.2019.06.005]
[5]赵 静.子宫内膜异位症患者子宫内膜组织中微RNA-143和丝裂原活化蛋白激酶7的表达[J].新乡医学院学报,2021,38(8):770.[doi:10.7683/xxyxyxb.2021.08.015]
 ZHAO Jing.Expression of microRNA-143 and mitogen activated protein kinase 7 in endometrium of patients with endometriosis[J].Journal of Xinxiang Medical University,2021,38(05):770.[doi:10.7683/xxyxyxb.2021.08.015]
[6]刘 莹,齐 英,赵 娟,等.子宫内膜异位症患者病灶切除术后自我管理行为与生存质量的相关性及影响因素分析[J].新乡医学院学报,2021,38(12):1147.[doi:10.7683/xxyxyxb.2021.12.008]
 LIU Ying,Qi Ying,ZHAO Juan,et al.Analysis of the correlation and influencing factors between self-management behavior and quality of life of patients with endometriosis after focal resection[J].Journal of Xinxiang Medical University,2021,38(05):1147.[doi:10.7683/xxyxyxb.2021.12.008]
[7]陈红霞,陈 霞,丁雪松,等.Ⅰ型子宫腺肌病患者放置左炔诺孕酮宫内节育系统前应用不同剂量米非司酮预处理疗效比较[J].新乡医学院学报,2021,38(12):1160.[doi:10.7683/xxyxyxb.2021.12.011]
 CHEN Hongxia,CHEN Xia,DING Xuesong,et al.Comparison of curative effect of different doses of mifepristone in pretreatment of type Ⅰ adenomyosis patients before placement of levonorgestrel-releasing intrauterine system[J].Journal of Xinxiang Medical University,2021,38(05):1160.[doi:10.7683/xxyxyxb.2021.12.011]
[8]涂 皎,牟 萌,古衡芳,等.左炔诺孕酮宫内缓释系统不同应用方法治疗子宫腺肌病疗效观察[J].新乡医学院学报,2019,36(1):033.[doi:10.7683/xxyxyxb.2019.01.007]
 TU Jiao,MOU Meng,GU Heng-fang,et al.Effect of different application methods of levonorgestrel intrauterine sustained-release system in the treatment of adenomyosis[J].Journal of Xinxiang Medical University,2019,36(05):033.[doi:10.7683/xxyxyxb.2019.01.007]
[9]郭耀省,孙 青.子宫内膜异位症的发病机制研究进展[J].新乡医学院学报,2018,35(5):439.[doi:10.7683/xxyxyxb.2018.05.022]
 N/A.N/A[J].Journal of Xinxiang Medical University,2018,35(05):439.[doi:10.7683/xxyxyxb.2018.05.022]
[10]王瑞歌,王世进.促性腺激素释放激素激动剂联合高强度聚焦超声治疗子宫腺肌病疗效观察[J].新乡医学院学报,2017,34(6):529.[doi:10.7683/xxyxyxb.2017.06.021]
 WANG Rui-ge,WANG Shi-jin.Effect of gonadotropin releasing hormone agonist combined with high intensity focused ultrasound in the treatment of patients with adenomyosis[J].Journal of Xinxiang Medical University,2017,34(05):529.[doi:10.7683/xxyxyxb.2017.06.021]

更新日期/Last Update: 2013-12-30